Corcept Therapeutics (CORT) Short Interest Ratio & Short Volume → Write this ticker symbol down… (From StocksToTrade) (Ad) Free CORT Stock Alerts $27.84 -0.78 (-2.73%) (As of 04:28 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corcept Therapeutics Short Interest DataCurrent Short Interest19,800,000 sharesPrevious Short Interest21,120,000 sharesChange Vs. Previous Month-6.25%Dollar Volume Sold Short$461.74 millionShort Interest Ratio18.0 Days to CoverLast Record DateApril 30, 2024Outstanding Shares104,110,000 sharesFloat Size89,710,000 sharesShort Percent of Float22.07%Today's Trading Volume596,591 sharesAverage Trading Volume1,405,785 sharesToday's Volume Vs. Average42% Short Selling Corcept Therapeutics ? Sign up to receive the latest short interest report for Corcept Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCORT Short Interest Over TimeCORT Days to Cover Over TimeCORT Percentage of Float Shorted Over Time Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Corcept Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202419,800,000 shares $461.74 million -6.3%22.1%18 $23.32 4/15/202421,120,000 shares $488.93 million -1.0%23.7%17.5 $23.15 3/31/202421,330,000 shares $537.30 million +5.5%23.9%15 $25.19 3/15/202420,220,000 shares $469.71 million +1.8%22.7%13 $23.23 2/29/202419,860,000 shares $466.71 million +1.1%22.3%13.1 $23.50 2/15/202419,640,000 shares $480.39 million +1.7%22.0%13.4 $24.46 Get the Latest News and Ratings for CORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202419,320,000 shares $407.65 million +23.3%22.0%14.4 $21.10 1/15/202415,670,000 shares $363.54 million +1.8%17.8%13.2 $23.20 12/31/202315,390,000 shares $499.87 million +0.9%17.5%17 $32.48 12/15/202315,260,000 shares $453.99 million -0.8%17.4%19.6 $29.75 11/30/202315,380,000 shares $391.73 million +0.7%17.5%21.2 $25.47 11/15/202315,270,000 shares $387.55 million +8.1%17.4%20.6 $25.38 10/31/202314,120,000 shares $396.49 million -5.6%16.1%19.4 $28.08 10/15/202314,960,000 shares $412.30 million -0.1%17.1%20 $27.56 9/30/202314,970,000 shares $407.86 million +3.4%17.1%20.8 $27.25 9/15/202314,480,000 shares $484.65 million -2.2%16.6%24.1 $33.47 8/31/202314,800,000 shares $484.40 million -0.5%17.0%23.7 $32.73 8/15/202314,870,000 shares $460.38 million -1.3%17.1%23.9 $30.96 7/31/202315,070,000 shares $383.98 million -4.2%17.3%23.9 $25.48 7/15/202315,730,000 shares $358.96 million -1.1%18.2%27.3 $22.82 6/30/202315,910,000 shares $354.00 million -5.1%18.4%25.2 $22.25 6/15/202316,770,000 shares $388.90 million +0.2%19.2%21.6 $23.19 5/31/202316,730,000 shares $392.99 million -2.3%19.2%20.9 $23.49 5/15/202317,130,000 shares $412.15 million No Change19.6%19.2 $24.06 10/31/202217,050,000 shares $487.63 million -0.8%18.3%30.1 $28.60 10/15/202217,190,000 shares $467.91 million -0.8%18.6%30.8 $27.22 9/30/202217,330,000 shares $444.34 million +1.5%18.7%29.7 $25.64 9/15/202217,070,000 shares $431.87 million -1.6%18.5%26.7 $25.30 8/31/202217,350,000 shares $447.98 million -1.0%18.8%27 $25.82 8/15/202217,530,000 shares $492.07 million -2.2%19.0%25.6 $28.07 7/31/202217,930,000 shares $513.87 million +1.1%19.0%22.4 $28.66 7/15/202217,730,000 shares $482.97 million -1.8%18.8%21.5 $27.24 6/30/202218,060,000 shares $429.47 million -0.6%17.5%20.5 $23.78 6/15/202218,170,000 shares $383.39 million -5.6%17.6%19.8 $21.10 5/31/202219,240,000 shares $400.96 million -5.2%20.4%20.1 $20.84 5/15/202220,300,000 shares $384.48 million +12.0%21.5%20.6 $18.94 4/30/202218,130,000 shares $389.98 million +9.5%19.2%18.7 $21.51 4/15/202216,560,000 shares $405.55 million +2.8%17.6%17.5 $24.49 3/31/202216,110,000 shares $362.80 million -2.8%N/A18 $22.52 3/15/202216,570,000 shares $397.68 million +2.3%17.6%16.7 $24.00New Options need New Trading Strategies (Ad)Zero-DTE options are the newest (and hottest) options to trade. Professional traders have rushed into the market and are making a mint. Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, Plus much more. Download Your Free "Zero-DTE Options Trading Secrets" report NOW! 2/28/202216,200,000 shares $361.10 million -0.9%17.1%9.6 $22.29 2/15/202216,340,000 shares $331.87 million -10.2%17.2%9.5 $20.31 1/31/202218,190,000 shares $341.43 million -5.2%17.6%10.5 $18.77 1/15/202219,180,000 shares $353.87 million +13.3%18.5%11.3 $18.45 12/31/202116,930,000 shares $335.21 million -12.9%16.3%10.2 $19.80 12/15/202119,440,000 shares $375.19 million +116.0%18.8%12.5 $19.30 11/30/20219,000,000 shares $189 million +0.5%8.7%9.8 $21.00 11/15/20218,960,000 shares $205.09 million -2.9%8.7%14.8 $22.89 10/29/20219,230,000 shares $166.14 million +9.9%8.9%17.9 $18.00 10/15/20218,400,000 shares $168.34 million -0.7%8.1%17.2 $20.04 9/30/20218,460,000 shares $166.49 million +0.8%8.1%17.5 $19.68 9/15/20218,390,000 shares $171.41 million +1.0%8.1%17 $20.43 8/31/20218,310,000 shares $176.84 million +3.1%8.0%15.8 $21.28 8/13/20218,060,000 shares $166.68 million +2.3%7.7%15.2 $20.68 7/30/20217,880,000 shares $163.67 million +3.1%7.6%13.3 $20.77 7/15/20217,640,000 shares $155.55 million -5.2%7.3%13.6 $20.36 6/30/20218,060,000 shares $177.32 million -18.5%7.7%14.4 $22.00 6/15/20219,890,000 shares $216.89 million -2.9%9.4%17.8 $21.93 5/28/202110,180,000 shares $219.89 million +3.0%9.7%19.9 $21.60 5/14/20219,880,000 shares $206.69 million -1.7%9.4%17.7 $20.92 4/30/202110,050,000 shares $235.77 million -5.4%9.6%17.5 $23.46 4/15/202110,620,000 shares $243.73 million +1.4%N/A0 $22.95 3/31/202110,470,000 shares $245.94 million -2.9%9.9%18 $23.49 3/15/202110,780,000 shares $276.94 million -0.2%10.2%17.6 $25.69 2/26/202110,800,000 shares $276.05 million No Change10.2%16.5 $25.56 2/12/202110,800,000 shares $309.64 million -4.7%10.3%13.6 $28.67 1/29/202111,330,000 shares $325.28 million -4.1%10.9%12.9 $28.71 1/15/202111,810,000 shares $326.19 million -0.7%11.3%12.9 $27.62 12/31/202011,890,000 shares $311.16 million -7.7%11.4%12.9 $26.17 12/15/202012,880,000 shares $330.37 million -6.1%12.3%13.5 $25.65 11/30/202013,720,000 shares $315.42 million -17.1%13.1%11.2 $22.99 11/15/202016,540,000 shares $299.21 million -5.7%15.8%5.7 $18.09 10/30/202017,530,000 shares $300.81 million -6.7%16.7%6.4 $17.16 10/15/202018,780,000 shares $345.18 million -1.4%18.0%6.6 $18.38 9/30/202019,040,000 shares $331.39 million +1.0%18.3%6.7 $17.41 9/15/202018,860,000 shares $334.20 million -18.6%18.1%6.5 $17.72 8/31/202023,160,000 shares $294.13 million +2.8%22.2%8.3 $12.70 8/14/202022,520,000 shares $310.10 million +1.9%21.6%21.2 $13.77 7/31/202022,100,000 shares $330.40 million -1.3%21.2%20.7 $14.95 7/15/202022,380,000 shares $365.02 million -1.2%21.7%22.8 $16.31 6/30/202022,650,000 shares $380.97 million +1.9%21.9%23.2 $16.82 6/15/202022,230,000 shares $338.56 million +1.0%21.5%22 $15.23 5/29/202022,020,000 shares $333.38 million -0.4%21.3%20.4 $15.14 5/15/202022,100,000 shares $310.73 million +0.9%21.4%19.2 $14.06 4/30/202021,910,000 shares $277.38 million -0.3%21.2%19.1 $12.66 4/15/202021,980,000 shares $262.44 million +5.5%21.3%19.6 $11.94 3/31/202020,830,000 shares $273.71 million -5.7%20.2%18.8 $13.14 3/13/202022,084,400 shares $269.65 million +2.8%21.4%16.6 $12.21 2/28/202021,480,000 shares $225.54 million +0.3%20.8%23.7 $10.50 2/14/202021,410,000 shares $242.79 million -6.6%19.8%23.4 $11.34Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 1/31/202022,910,000 shares $310.20 million +1.0%21.2%22.5 $13.54 1/15/202022,680,000 shares $313.44 million +3.1%21.0%23.2 $13.82 12/31/201922,000,000 shares $287.32 million +0.4%21.4%23.1 $13.06 8/15/201923,377,700 shares $292.46 million -4.4%22.6%33.8 $12.51 CORT Short Interest - Frequently Asked Questions What is Corcept Therapeutics' current short interest? Short interest is the volume of Corcept Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 19,800,000 shares of CORT short. 22.07% of Corcept Therapeutics' shares are currently sold short. Learn More on Corcept Therapeutics' current short interest. What is a good short interest ratio for Corcept Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CORT shares currently have a short interest ratio of 18.0. Learn More on Corcept Therapeutics's short interest ratio. Which institutional investors are shorting Corcept Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corcept Therapeutics: Walleye Trading LLC, Ikarian Capital LLC, Jane Street Group LLC, Kynam Capital Management LP, HAP Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corcept Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.07% of Corcept Therapeutics' floating shares are currently sold short. Is Corcept Therapeutics' short interest increasing or decreasing? Corcept Therapeutics saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 19,800,000 shares, a decrease of 6.3% from the previous total of 21,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Corcept Therapeutics' float size? Corcept Therapeutics currently has issued a total of 104,110,000 shares. Some of Corcept Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corcept Therapeutics currently has a public float of 89,710,000 shares. How does Corcept Therapeutics' short interest compare to its competitors? 22.07% of Corcept Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corcept Therapeutics: Perrigo Company plc (2.54%), Harmony Biosciences Holdings, Inc. (16.05%), Taro Pharmaceutical Industries Ltd. (0.68%), Supernus Pharmaceuticals, Inc. (9.16%), Xencor, Inc. (10.83%), Pacira BioSciences, Inc. (7.73%), OPKO Health, Inc. (26.42%), ADC Therapeutics SA (1.43%), Atea Pharmaceuticals, Inc. (2.43%), Jazz Pharmaceuticals plc (5.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Corcept Therapeutics stock? Short selling CORT is an investing strategy that aims to generate trading profit from Corcept Therapeutics as its price is falling. CORT shares are trading down $0.78 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corcept Therapeutics? A short squeeze for Corcept Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CORT, which in turn drives the price of the stock up even further. How often is Corcept Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Perrigo Short Squeeze Harmony Biosciences Short Squeeze Taro Pharmaceutical Industries Short Squeeze Supernus Pharmaceuticals Short Squeeze Xencor Short Squeeze Pacira BioSciences Short Squeeze OPKO Health Short Squeeze ADC Therapeutics Short Squeeze Atea Pharmaceuticals Short Squeeze Jazz Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CORT) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNew Options need New Trading StrategiesNetpicksForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin Analytics